150
P. Bagi et al. / Journal of Organometallic Chemistry 797 (2015) 140e152
with an ee of 23% and spiro-TADDOL [(ꢀ)-5]. 0.91 g (1.8 mmol) of
spiro-TADDOL [(ꢀ)-5] was added to this mixture and the resolution
was performed in 11.5 mL of methanol according to Representative
Procedure I. The [(R)-3∙(spiro-TADDOL)2] complex was purified by
two recrystallizations in 11.5 mL of methanol and it was decom-
posed by column chromatography (silica gel, dichloromethane-
methanol 97:3) to give 0.14 g (40%) of (R)-1-isopropyl-3-methyl-
3-phospholene 1-oxide [(R)-3] in an ee of 87%.
4.8. Preparation of 1-isopropyl-3-methyl-3-phospholene-borane
(9)
The solution of 0.11 g (0.68 mmol) of racemic 1-isopropyl-3-
methyl-3-phospholene 1-oxide (3) in
2 mL of toluene was
degassed and cooled to 0 ꢁC, then 0.56 mL (4.1 mmol) of tri-
chlorosilane was added. The mixture was stirred at 0 ꢁC for 3 h and
then at 26 ꢁC for 3 h under nitrogen to afford the corresponding
phospholene (8) that was immediately reacted further. 0.34 mL of
2 M dimethyl sulfide borane in tetrahydrofuran (0.68 mmol) was
added and the solution was stirred at 26 ꢁC for 3 h under nitrogen.
Then, the mixture was treated with 3 mL of water and stirred for
15 min. The precipitated boric acid was removed by filtration and
the organic phase dried (Na2SO4). Volatile components were
removed under reduced pressure and the residue so obtained was
purified by column chromatography (silica gel, 3% methanol in
dichloromethane) to give 0.041 g (38%) of 1-isopropyl-3-methyl-3-
4.6. Resolution of 1-isopropyl-3-methyl-3-phospholene 1-oxide (3)
with calcium hydrogen O,O0-dibenzoyl-(2R,3R)-tartrate [(ꢀ)-6]
(Representative Procedure II.)
To 0.14 g (0.17 mmol) of Ca(H-DBTA)2∙(H2O)2 [(ꢀ)-6∙(H2O)2] in
0.40 mL of hot ethanol was added 0.11 g (0.69 mmol) of racemic
1-isopropyl-3-methyl-3-phospholene 1-oxide (3) in 0.40 mL of
ethanol. After the addition, the solution was allowed to cool to
26 ꢁC, whereupon colourless crystals appeared. After standing
at 26 ꢁC for 24 h, the crystals were filtered off to give 0.60 g (33%) of
phospholene-borane (9). 1H NMR (CDCl3)
1.12 (d, J ¼ 7.1, 3H) and 1.18 (d, J ¼ 7.1, 3H) CH(CH3)2, 1.80 (bs, 3H,
d 0.35e1.04 (m, 3H, BH3),
d
C3eCH3), 1.84e1.97 (m, 1H, CH(CH3)2), 2.34e2.56 (m, 4H, CH2PCH2),
Ca[((R)-3)2(H-DBTA)2] with
a de of 35%. The diastereomeric
5.43 (m, 1H, CH ¼ ); 13C NMR (CDCl3)
d
16.6 and 16.7 CH(CH3)2, 19.1
0
complex was purified further by one digestion, by stirring the
suspension of the diastereomeric complex at 26 ꢁC in 0.80 mL of
ethanol for 24 h to give 0.022 g (12%) of Ca[((R)-3)2(H-DBTA)2]
with a de of 43%. The (R)-1-isopropyl-3-methyl-3-phospholene
1-oxide [(R)-3] was recovered from the diastereomeric complex
by treatment of the 2 mL dichloromethane suspension of Ca
[((R)-3)2(H-DBTA)2] with 2 mL of a 10% aqueous ammonia. The
organic layer was washed with 0.5 mL of water, dried (Na2SO4), and
concentrated to give 0.004 g (8%) of (R)-1-isopropyl-3-methyl-3-
phospholene 1-oxide [(R)-3] with an ee of 43% (Table 3, Entry 1).
Resolution of isopropyl-3-methyl-3-phospholene 1-oxide (3)
with Ca(H-DBTA)2 [(ꢀ)-6] was also performed in a mixture of
ethanol and ethyl acetate and that of ethanol and acetonitrile ac-
cording to Representative Procedure II. The conditions and the re-
sults are shown in Table 3, Entries 2 and 3.
1
(3JP-C ¼ 7, C3eCH3), 24.1 (1JP-C ¼ 31, C1 ), 28.4 ( JP-C ¼ 33, C5), 32.2
(1JP-C ¼ 35, C2), 122.2 (C4), 138.2 (2JP-C ¼ 3, C3); 31P NMR (CDCl3)
d
42.9 (broad); ½M þ Naꢃþfound ¼ 179.1137, C8H18PBNa requires
179.1137 for the 11B isotope.
The optically active (R)-1-isopropyl-3-methyl-3-phospholene-
borane [(R)-9] was prepared in a similar manner from (S)-1-
isopropyl-3-methyl-3-phospholene 1-oxide [(S)-3] with an ee of
97%. Yield of (R)-9: 40%; 1H NMR (CDCl3)
d
0.40e1.05 (m, 3H, BH3),
d
1.12 (d, J ¼ 7.0, 3H) and 1.18 (d, J ¼ 7.0, 3H) CH(CH3)2, 1.80 (bs, 3H,
C3eCH3),1.86e1.97 (m, 1H, CH(CH3)2), 2.32e2.55 (m, 4H, CH2PCH2),
5.43 (m, 1H, CH ¼ ); 13C NMR (CDCl3)
d
16.6 and 16.7 CH(CH3)2, 19.2
0
(3JP-C ¼ 7, C3eCH3), 24.0 (1JP-C ¼ 31, C1 ), 28.4 ( JP-C ¼ 33, C5), 32.1
1
(1JP-C ¼ 35, C2), 122.2 (C4), 138.2 (2JP-C ¼ 3, C3); 31P NMR (CDCl3)
d
43.2 (broad); [½aꢃ2D5 ¼ þ3.8 (c 1, CHCl3)].
4.9. Preparation of cis-[bis(1-isopropyl-3-methyl-3-phospholeno)-
dichloro-platinum(II)] (10)
4.7. Resolution of 1-isopropyl-3-methyl-3-phospholene 1-oxide (3)
with calcium hydrogen O,O0-di-p-toluoyl-(2R,3R)-tartrate [(ꢀ)-7]
(Representative Procedure III.)
The deoxygenation of 0.067 g (0.43 mmol) of racemic 1-
isopropyl-3-methyl-3-phospholene 1-oxide (3) was carried out in
benzene using 0.26 mL (2.6 mmol) of trichlorosilane according to
the procedure described in Section 4.8. Then, 0.10 g (0.21 mmol) of
dichlorodibenzonitrile-platinum(II) was added to the reaction
mixture under nitrogen. The mixture was stirred at 26 ꢁC for 1 day,
whereupon the complex precipitated. Separation by filtration led to
0.10 g (87%) of 10 as a 2:1 mixture of the hetero- (R,S) and homo-
To 0.19 g (0.48 mmol) of DPTTA∙H2O in a mixture of 0.60 mL of
ethanol and 0.06 mL of water was added 0.014 g (0.24 mmol) of
CaO, and the mixture was heated at the boiling point until it
became clear. 0.15 g (0.97 mmol) of racemic 1-isopropyl-3-methyl-
3-phospholene 1-oxide (3) in 0.60 mL of ethyl acetate was
then added to the solution of the in situ formed resolving agent
Ca(H-DPTTA)2 [(ꢀ)-7]. After the addition, the solution was allowed
to cool down to 26 ꢁC, whereupon colourless crystals appeared.
After standing at 26 ꢁC for 24 h, the crystals were filtered off to give
0.12 g (45%) of Ca[((S)-3)2(H-DPTTA)2] with a de of 46%. The
diastereomeric complex was purified further by two digestions, by
stirring the suspension of the diastereomeric complex at 26 ꢁC for
24 h in a mixture of 0.60 mL of ethanol and 0.60 mL of ethyl acetate
to give 0.038 g (14%) Ca[((S)-3)2(H-DPTTA)2] with a de of 92%.
The (S)-1-isopropyl-3-methyl-3-phospholene 1-oxide [(S)-3]
was recovered from the corresponding diastereomeric complex
similarly to the procedure described in Section 4.6 to afford 0.008 g
(10%) of (S)-1-isopropyl-3-methyl-3-phospholene 1-oxide [(S)-3]
with an ee of 92% (Table 3, Entry 5).
chiral [(R,R) and (S,S)] forms. 1H NMR (CDCl3)
d 1.13e1.24 (m, 12H,
CH(CH3)2), 1.81 (bs, 6H, C3eCH3), 2.51e2.63 (m, 2H, CH(CH3)2),
2.74e3.12 (m, 8H, CH2PCH2), 5.47 (m, 2H, CH ¼ ); 13C NMR (CDCl3)
d
17.8e17.9 (m) and 18.1e18.3 (m) CH(CH3)2 of the homochiral
form, 17.9e18.1 (m, CH(CH3)2 of the heterochiral form), 18.8e18.9
0
(m, C3eCH3), 27.7e28.1 (m, C1 ), 30.5e31.2 (m, C5), 34.4e35.0 (m,
C2), 122.7 (3JPt-C ¼ cannot be observed, C4 of the homochiral form),
122.9 (3JPt-C ¼ 29, C4 of the heterochiral form),138.9e139.0 (m, C3 of
the heterochiral form), 139.2e139.3 (m, C3 of the homochiral form);
31P NþMR (CDCl3)
and 195Pt isotopes.
d
29.7 (1JPt-P
¼
3489); HRMS
½M ꢀ Clꢃfound ¼ 513.1146, C16H30P2ClPt requires 513.1138 for the 35Cl
The optically active cis-[bis-(S)- 1-isopropyl-3-methyl-3-
phospholeno)-dichloro-platinum(II)] [(S,S)-10] was prepared in a
similar manner from (S)-1-isopropyl-3-methyl-3-phospholene 1-
Resolution of isopropyl-3-methyl-3-phospholene 1-oxide (3)
with Ca(H-DPTTA)2 [(ꢀ)-7] was also performed in a mixture of
ethanol and water and that of ethanol, water and acetonitrile ac-
cording to Representative Procedure III. The conditions and the re-
sults are shown in Table 3, Entries 4 and 6.
oxide [(S)-3] with an ee of 97%. Yield of (R)-9: 75%. ½aꢃ2D5 ¼ þ18.8
(c 1, CHCl3); 1H NMR (CDCl3)
d
1.15 (dd, 3JH-H ¼ 7.1, 3JP-H ¼ 16.7, 6H,